394 related articles for article (PubMed ID: 15332786)
1. Measles immunization in Saudi Arabia: the need for change.
Khalil MK; Al-Mazrou YY; Al-Jeffri M; Al-Ghamdy YS
East Mediterr Health J; 2001; 7(4-5):829-34. PubMed ID: 15332786
[TBL] [Abstract][Full Text] [Related]
2. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
4. Seroresponse to the second measles vaccine dose at school entry in Qassim province, Saudi Arabia.
Khalil MK; Nadrah HM; Al Yahia OA; ElGhazali G
East Mediterr Health J; 2011 Mar; 17(3):191-5. PubMed ID: 21735958
[TBL] [Abstract][Full Text] [Related]
5. Sustained measles elimination in Australia and priorities for long term maintenance.
Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
[TBL] [Abstract][Full Text] [Related]
6. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
[TBL] [Abstract][Full Text] [Related]
7. Sero-response to measles vaccination at 12 months of age in Saudi infants in Qassim Province.
Khalil MK; Nadrah HM; Al-Yahia OA; Al-Saigul AM
Saudi Med J; 2008 Jul; 29(7):1009-13. PubMed ID: 18626531
[TBL] [Abstract][Full Text] [Related]
8. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
[TBL] [Abstract][Full Text] [Related]
9. Sero-response to measles-mumps-rubella vaccine campaign in Saudi Arabia.
Al-Mazrou YY; Khalil MK; Tumsah S; Al-Ghamdi YS; Al-Jeffri MH; Tischer AB; Mishkhas AA; Eissa M
Saudi Med J; 2002 Jun; 23(6):680-3. PubMed ID: 12070547
[TBL] [Abstract][Full Text] [Related]
10. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
11. Predicting and comparing long-term measles antibody profiles of different immunization policies.
Lee MS; Nokes DJ
Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
[TBL] [Abstract][Full Text] [Related]
12. MMR vaccination: new thought.
Deshmukh V
Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
[No Abstract] [Full Text] [Related]
13. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
15. The measles/rubella immunisation campaign in Scotland.
Skinner R; Christie P; Cowden JM
Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
[TBL] [Abstract][Full Text] [Related]
16. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
Kim SS; Han HW; Go U; Chung HW
Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
[TBL] [Abstract][Full Text] [Related]
17. Measles epidemiology and its implications for a vaccination programme in Oman.
Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
[TBL] [Abstract][Full Text] [Related]
18. The Measles Control Campaign and immunisation adverse events.
Burgess MA; Heath TC; McIntyre PB
Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
[No Abstract] [Full Text] [Related]
19. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
Kelly HA; Gidding HF; Karapanagiotidis T; Leydon JA; Riddell MA
BMC Public Health; 2007 Jun; 7():99. PubMed ID: 17555601
[TBL] [Abstract][Full Text] [Related]
20. The Australian Measles Control Campaign, 1998.
Turnbull FM; Burgess MA; McIntyre PB; Lambert SB; Gilbert GL; Gidding HF; Escott RG; Achat HM; Hull BP; Wang H; Sam GA; Mead CL
Bull World Health Organ; 2001; 79(9):882-8. PubMed ID: 11584738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
